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Neurobiology of Disease
Contrast-Enhanced Magnetic Resonance Microangiography
Reveals Remodeling of the Cerebral Microvasculature in
Transgenic ArcAMice
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Amyloid- (A) deposition in the cerebral vasculature is accompanied by remodeling which has a profound influence on vascular
integrity and function. In the current study we have quantitatively assessed the age-dependent changes of the cortical vasculature in the
arcA model of cerebral amyloidosis. To estimate the density of the cortical microvasculature in vivo, we used contrast-enhanced
magnetic resonance microangiography (CE-MRA). Three-dimensional gradient echo datasets with 60 m isotropic resolution were
acquired in 4- and 24-month-old arcAmice and compared with wild-type (wt) control mice of the same age before and after adminis-
tration of superparamagnetic iron oxide nanoparticles. After segmentation of the cortical vasculature from difference images, an auto-
mated algorithm was applied for assessing the number and size distribution of intracortical vessels. With CE-MRA, cerebral arteries
and veins with a diameter of less than the nominal pixel resolution (60m) can be visualized. A significant age-dependent reduction in
the number of functional intracorticalmicrovessels (radii of 20–80m) has been observed in 24-month-old arcAmice comparedwith
age-matched wt mice, whereas there was no difference between transgenic and wt mice of 4 months of age. Immunohistochemistry
demonstrated strong fibrinogen and A deposition in small- andmedium-sized vessels, but not in large cerebral arteries, of 24-month-
old arcAmice. The reduced density of transcortical vesselsmay thus be attributed to impaired perfusion and vascular occlusion caused
by deposition of A and fibrin. The study demonstrated that remodeling of the cerebrovasculature can bemonitored noninvasively with
CE-MRA in mice.
Introduction
Cerebral amyloid angiopathy (CAA) results from the failure to
eliminate amyloid- (A) and other amyloid peptides from the
cerebral vasculature in aged people and patients with Alzheimer‘s
disease (AD; Glenner et al., 1981; Weller et al., 2008, 2009). A
accumulates predominantly in cerebral microvessels such as cap-
illaries and arterioles (Fischer at al., 1990; Buee et al., 1994; Miao
et al., 2005; Kouznetsova et al., 2006)where it leads to an impeded
cerebral blood supply, reduced vascular reactivity, and increased
susceptibility to cerebral ischemia (Gilbert and Vinters, 1983;
Cadavid et al., 2000; Haglund et al., 2006; Ryu and McLarnon,
2009). These changes in hemodynamic conditions result in long-
term structural changes known as vascular remodeling. Blood
vessels become tortuous, the composition of the basement mem-
brane is altered (de la Torre, 1997; Moody et al., 1997), and the
overall vascular density decreases (Lee et al., 2005; Bouras et al.,
2006). Furthermore, changes in the proteolytic microenviron-
ment lead to impairment of blood–brain-barrier (BBB) integrity
and the occurrence of cerebral microbleeds (CMBs) and intrace-
rebral hemorrhage (Gilbert and Vinters, 1983; Franceschi et al.,
1995; Ryu and McLarnon, 2009). There is increasing evidence
that vascular remodeling might not only reflect an adaptive pro-
cess, but also constitutes an important mechanism in the patho-
physiology of AD and CAA (Weller et al., 2009; Marchesi, 2011).
Cerebrovascular A deposition can be mimicked in mouse
models, which, therefore, have become central for studying the
pathophysiology of CAA and evaluating novel therapeutic ap-
proaches (Calhoun et al., 1999; Herzig et al., 2004; Miao et al.,
2005; Kouznetsova et al., 2006). Recently, the arcA mouse line
has been generated, which shows age-dependent cerebrovascular
dysfunction as reflected by BBB impairment, neurovascular un-
coupling (Merlini et al., 2011), decreased vascular reactivity
(Princz-Kranz et al., 2010), and the occurrence of cerebral mi-
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crobleeds (Klohs et al., 2011; Merlini et al., 2011). Based on these
findings, we hypothesized that the arcAmice would showCAA-
related remodeling of the cerebral microvasculature. We used
high-resolution contrast-enhanced magnetic resonance angiog-
raphy (CE-MRA) in 4- and 24-month-old arcAmice and age-
matched wild-type (wt) control mice to assess age-dependent
changes in the cerebral vasculature. Aged arcAmice exhibited a
significant reduction in density of functional intracorticalmicroves-
selswith radii in the range of 20–80m,while large cerebral vessels,
as detected with conventional time-of-flight MRA (TOF-MRA),
werenot affected.This in vivoobservation is in linewith resultsof the
immunohistochemistry revealing that A and fibrinogen are pre-
dominantly deposited in small- andmedium-sized vessels, but spare
larger cerebral vessels. Hence, the reduced density of intracortical
vessels observed in advanced disease may be attributed to obstruc-
tion of perfusion as a result of abnormal fibrinolysis. In murine
models of cerebral amyloidosis, the remodeling of these vascular
structures can bemonitored noninvasively with CE-MRA.
Materials andMethods
Animals. All experiments were performed in accordance with the Swiss
Federal Act on Animal Protection. We used arcA transgenic mice of
either sex, which express the human APP 695 containing both the Swed-
ish and the Arctic mutation under the control of the prion protein pro-
moter as described previously (Knobloch et al., 2007). Age- and gender-
matched wt littermates served as controls. Mice at the age of 4 months
(arcA, n 4; wt, n 4) and 24 months (arcA, n 6; wt, n 5) were
used for the study. Animals were kept at standard housing conditions
(temperature, 20–24°C; relative humidity, minimum 40%; light/dark
cycle, 12 h) providing water and food ad libitum.
Magnetic resonance imaging. Experiments were performed on a Bruker
BioSpec 94/30 (Bruker BioSpin) small animal MR system operating at
400 MHz with a gradient system, capable of a maximum gradient
strength of 400mT/mwith an 80s rise time. A cryogenic quadrature RF
surface coil (Bruker BioSpin) was used for RF signal transmission and
reception (Baltes et al., 2009). Anesthesiawas inducedwith 3% isoflurane
(Abbott) in a 4:1 air/oxygen mixture and maintained with 1.2% isoflu-
rane. Mice were endotracheally intubated and mechanically ventilated
with 90 breaths/min, applying a respiration cycle of 25% inhalation and
75% exhalation (MRI-1 Volume Ventilator, CWI). Temperature was
kept at 36.0  0.5°C using a warm-water circuit integrated into the
animal support (Bruker BioSpin). Body temperature was monitored
with a rectal temperature probe (MLT415, ADInstruments). The tail
veins of the mice were cannulated for administration of contrast agents.
Tri-pilot scans were used for accurate positioning of the animal head
inside the magnet. For high-resolution structural imaging, we used a 2D
FLASH sequence with the parameter TE/TR 8/345 ms; RF pulse angle,
  30°; bandwidth  50 kHz; number of averages (NA)  1. Fifteen
0.5-mm-thick slices with an interslice distance of 0.6 mm were acquired
with a field of view (FOV) of 20  20 mm2 and matrix dimension of
384  384, resulting in a spatial resolution of 52  52 m2. For TOF-
MRA a 3D FLASH sequence with the parameters TE/TR  2.5/15 ms,
  30°, bandwidth  98 kHz, NA  2 was used. A horizontal slab of
19.8 15.9 8 mm3 was recorded using a matrix dimension of 248
199  100, resulting in isotropic voxel dimensions of 80 m3. The ac-
quisition time was 7 min and 27 s. For CE-MRA, precontrast and
postcontrast images were acquired using a 3D FLASH sequence with
TE/TR 2.9/150 ms,  20°, bandwidth 82 kHz, NA 2. A slab of
15  12  2.2 mm3 was recorded with matrix dimensions of 248 
199 36 with a spatial resolution of 60 60 61 m3. Animals were
injected intravenously with 50 l of an iron-oxide contrast agent (corre-
sponding to 0.52 mg of Fe; Endorem, Guerbet) as a bolus into the tail
vein.Thepostcontrast imageacquisitionwas started1minafter the injection
of the contrast agent. The acquisition time was 36min for each scan.
Determination of contrast-to-noise ratios. Regions of interest (ROIs)
were drawn in vessels and adjacent tissue of precontrast images. A noise
ROI was placed outside the head of the animal. Signal-to-noise (SNR)
ratios were calculated by dividing the signal intensity of the vessel ROI by
the SD of the noise ROI. SNR values were calculated for four regions
separately and then averaged.
Reconstruction of angiograms. For TOF-MRA datasets, angiograms
were generated by maximum intensity projections (MIPs) using Paravi-
sion 5.0 (Bruker BioSpin MRI). All angiograms were evaluated by inves-
tigators blinded to the genotype of the mouse. MIPs of TOF-MRA were
inspected from various projection angles. Flow voids were detectedwhen
the signal intensities in an identified blood vessel reached background
level. Distalitywas counted by assessing the number of visible branches of
the anterior cerebral artery (Fig. 1C,D). Distality count, i.e., the number
of hierarchical levels of vascular branches detected, was only estimated
forMIPs of TOF-MRA data, because for CE-MRA the whole vessel tree
was not covered in the acquisition.
ForCE-MRA, difference imageswere first obtained by subtraction of
the postcontrast image from the precontrast image before MIP genera-
tion using home-written software based on IDL (Interactive Data Lan-
guage, version 6.4; ITT Visual Information Solutions).
Assessment of vessel number and vessel radius. For segmentation of the
cerebral cortex, ROIs were drawn for each animal on each 61-m-thick
Figure 1. High-resolution 3D TOF-MRA of the intracranial and extracranial vasculature of a 24-month-old wt control mouse (A) and an age-matched arcA mouse (B). The representative
maximal intensity projections show the angiograms in sagittal, axial, and horizontal views.While the intracranial vasculature of arcA andwtmice shows no flow disturbances, flow voids are seen
in extracranial vessels (white arrows). Sections of MIPs of the anterior cerebral artery of a 4-month-old (C) and a 24-month-old (D) wt control mouse. Discernable bifurcations are numbered in
hierarchical order. More distal branches are visible in the angiogram of the 4-month-old mouse (C, white arrowhead). Scale bar, 1 mm.
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slice of the 3D dataset. The ROIs were chosen to encompass both hemi-
spheres of the neocortex over a depth of 430 m. To exclude meningeal
vasculature, superficial brain slices to a depth of 350mbelow the brain
surface were not considered in the ROI analysis. A noise ROI was placed
outside the brain. The selected ROIs were combined to define a volume
of interest (VOI) required for the subsequent 3D vessel analysis. In this
algorithm, vessel structures were identified according to the following
two threshold criteria: A voxel was considered to belong to a vessel, if (1)
the signal of the voxel was higher than the signal threshold (SThreshold) as
defined in Equation 1, and (2) the number of connected voxels was equal
to or higher than the connectivity threshold. SThreshold was defined ac-
cording to
SThreshold  SROI,Noise  tNoise  SDSROI,Noise), (1)
where SROI,Noise and SD(SROI,Noise) define the average and the SD, respec-
tively, of the signal in the noise ROI defined outside of the object of interest
(in a corner of the field-of-view). The parameter tNoise could be chosen
interactively. Unless indicated otherwise, we used a value of tNoise 8.
For voxels fulfilling this threshold criterion, a 3D search algorithmwas
applied searching for voxels connected along edges or corners. Structures
for which the number of connected voxels exceeded the connectivity
threshold set to 3, 6, and 9 were considered as vessels.
The intensity of a vascular signal depends on the relative voxel volume
taken by the vascular compartment. Correspondingly, evaluation of
these partial volume effects allowed estimating the compartment size and
thus an upper limit for the vessel dimensions. For this purpose we as-
sumed a perpendicular orientation of the vessel with respect to the im-
aging slices. For transcortical vessels oriented radially with regard to the
cortical surface, this approximation appears reasonable. Within each
slice the voxel with the highest signal intensity Sk,max in the difference
images was assumed to comprise only the vascular compartment. Ac-
cordingly, the radius of the i-th cross-sectional vessel in the k-th imaging
slice was calculated as
rik 
v  SikvSk,max  AVoxel

(2)
whereAVoxel is the cross-sectional area of one voxel and the summation is
running over all voxels v in slice k contributing to vessel i. The average
vessel radius ri is then obtained by averaging the values rik across all slices
displaying the vessel.
Immunohistochemistry. All animals were deeply anesthetized by intra-
peritoneal injection of ketamine/xylazine (100/20 mg/kg body weight)
and perfused transcardially with PBS (pH 7.4), followed by 4% parafor-
maldehyde in PBS (Sigma-Aldrich Chemie). Brains were then embedded
in paraffin and cut into 10-m-thick horizontal sections. The sections
were pretreated in 85°C Na-Citrate buffer (0.1 M, pH 4.5, in the micro-
wave), followed by a 5 min submersion in 95% formic acid. Blocking of
Figure 2. Precontrast (A, D) and postcontrast (B, E) images were acquired before and after administration of a superparamagnetic iron oxide contrast agent. Grayscale windowing was kept
identical for both images. Difference images (C,F ) are obtainedby subtraction of thepostcontrast image from theprecontrast image. Depicted are representative horizontal images of the cortex and
olfactory bulb of a 24-month-old wt mouse (A–C) and an age-matched arcAmouse (D–F ). After administration of the contrast agent, hypointensities representing intact blood vessels become
visible which are not discernable on the precontrast image. The arrows point to focal hypointense areas that are present before administration of the contrast agent. Scale bar: 1 mm.
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nonspecific binding was done in a mixture of 4% BSA, 5% normal goat
serum, and 5% horse serum in PBS for 1 h at room temperature. The
sections were then incubated overnight at 4°C in the primary antibody
solution containing mouse antifibrinogen antibodies (Abcam, catalog
#52861, 1:1000) or rabbit anti-vonWillebrand factor (vWF, Novocastra,
catalog #NCL-vWFp, 1:500) in PBS containing 2% normal goat serum
and 0.2% Triton X-100. After three washes in PBS, tissue sections were
incubated for 30 min at room temperature in corresponding secondary
antibodies coupled to Cy3 (diluted 1:500; Jackson ImmunoResearch).
Thioflavin S counterstaining involved 10 min incubation in filtered 1%
aqueous thioflavin S (Sigma-Aldrich) solution at room temperature, fol-
lowed by two washes for 5 min in 80% EtOH, 5 min wash in 95% EtOH,
and three 5 min washes in distilled water. Brain sections were then air-
dried in the dark and mounted with aqueous permanent mounting me-
dium containing DAPI for nuclear counterstainings (DAKO).
Analysis of immunohistochemical stainings. Qualitative evaluation of
the immunofluorescence labeling was done with a confocal microscope
(LSM-710, Zeiss) using the 40 (NA1.3) objective. Double immunoflu-
Figure 3. MIPs derived from a 3D stack of difference images viewed in horizontal (A), sagittal (B–D), and axial (E) orientation. The projections A andBwere acquired over the whole acquisition
volume, covering 2.2mmof the upper part of themouse brain. The horizontal view is dominated by projections of superficial veins like the transverse and superior sagittal sinus. Subcubes C–Ewere
taken from the axial MIP (location in the brain is indicated by the dashed line in A). The cerebral vasculature is highly organized, running perpendicular to the cortical surface.
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orescence staining was visualized using sequential acquisition of each
channel. The pinhole aperture was set to 1.0 Airy unit for each channel.
Stacks of consecutive optical sections (6; 512 512 pixels, spaced 0.5m
in z) were acquired. For visual display, Z-sections of both channels were
projected in the z-dimension (maximal intensity), and merged using the
image analysis software Imaris (Bitplane). Cropping of images and ad-
justments of brightness and contrast were identical for each labeling and
done using Adobe Photoshop (Adobe Systems).
Quantitative analyses of the vWF-immunoreactivity associated with
the endothelial cells of the cerebral vasculature were done on three
different horizontal brain sections obtained from 5 mice per age and
genotype. Two digital images per brain hemisphere were acquired using
a 40 (NA1.3) objective. The area covered by the immunoreactive signal
was quantified using a threshold algorithm of ImageJ software. The bi-
nary images were segmented and the individual vessels outlined. The
correspondingmasks were analyzed with regard to the total area covered
by the anti-vWF immunoreactivity. The different measures were aver-
aged per animal and included in the statistical analysis.
For the quantitative evaluation of the fibrinogen accumulation and
colocalization with thioflavin S associated with vascular plaques, three
different brain sections per animal (n  5 per age and genotype) were
included. For each hemisphere, one digital tile-scan (1.0 0.76mm)was
acquired using a 20 Apochromate objective (Zeiss, NA 0.75). First, red
and green channels were individually segmented and then analyzed with
regard to pixel overlap within outlined vessels using a colocalization
plug-in of ImageJ (NIH). The diameter of the vessels showing colocalized
thioflavin S/fibrinogen immunoreactivity was recorded and the cumula-
tive distribution and frequency calculated as a function of their size.
Statistical analysis. Data are presented as mean SD. Student’s t test,
1-way ANOVA, or repeated-measures ANOVA followed by Tukey’s test
(SigmaStat 3.0, Systat Software) were used for statistical comparison,
where appropriate. The statistical significance level was set to p 0.05.
Results
Assessment of vessel status with angiograms
To evaluate the effect of A deposition onmajor cerebral arteries,
3D TOF angiograms have been recorded in wt and arcAmice at
4 months (n  4 each) and 24 months (n  6 each) of age. In
TOF-MRA the signal arises from fully magnetized blood that has
entered the imaging volume and reached the respective vascular
voxel in a defined time interval (flow encoding time), without the
need of administering a contrast agent (Reese et al., 1999). MIPs
displayed in different orientations allow clear identification of
major intracranial arteries as illustrated for a 24-month-old wt
and arcA mouse (Fig. 1A,B). No apparent flow abnormalities
could be detected in the vessels of wt control and arcA mice at
both ages. The distality count did not reveal any trait-specific
difference at either age, yielding values of 4.2 0.4 and 4.2 0.4
for 4-month-old wt and arcAmice and 3.5 0.4 and 3.5 0.5
for 24-month-old wt and arcAmice, respectively. The distality
value tended to be slightly lower in aged animals, though the
difference was not significant (Fig. 1C,D). Interestingly, flow
voids were detected in extracranial vessels such as the pterygopal-
atine arteries of wt and arcAmice at both ages (for 24 months,
Fig. 1A,B, white arrows). Again, no difference was observed be-
tween wt and arcAmice.
Visualization of vascular structures can be enhanced using
intravascular contrast agents such as iron oxide nanoparticles,
which, due to their large net positive magnetic moments, induce
spin dephasing resulting in a net signal loss (Boxerman et al.,
1995; Bolan et al., 2006). Figure 2 displays representative hori-
zontal images of the brain of a 24-month-old wt control and
an arcA mouse. Following the administration of Endorem,
transcortical blood vessels became visible as focal signal voids
that could not be discerned on the precontrast image (Fig. 2B,E)
and could be enhanced in difference images, as nonvascular brain
structureswere canceling out (Fig. 2C,F).Wenoticed remarkable
variations in the signal intensity of the vascular structures in the
difference images. This is attributed to partial volume effects.
This intensity information can, in turn, be used to estimate the
size of the vascular compartment within a voxel, from which a
maximum vessel diameter might be deduced (assuming that the
vascular compartment is due to a single vessel crossing the voxel).
Several large circular hypointensities (mean diameter of 242.5
108.1 m) have been observed in the brains of 24-month-old
arcA mice already before the administration of the contrast
agent (Fig. 2D, white arrow). Such structures have not been ob-
served in the brains of 4-month-old arcA mice and 4- and 24-
month-old wt control mice and represent most likely either large
Figure 4. Semiautomated analysis of intracortical vessel density of wt and arcAmice at 4
and24months of age.A, The relativenumber of vesselswas estimated for different connectivity
thresholds corresponding to 3, 6, and 9 pixels, corresponding to minimal length of a vessel
segment of 183, 366, and 546m, respectively.B, Number of vessels categorized according to
their estimated vessel radius when the connectivity threshold was set to 3. The algorithm
counts the fraction of vessels above an intensity threshold for different values of vessel connec-
tivity in a VOI covering the cortex. A significant decrease in the number of vessels was observed
in 24-month-old arcA compared with wt controls, while no significant differences were seen
between arcAmice and wt controls at 4 months of age (mean SD; *p 0.05, repeated-
measures ANOVA and Tukey‘s test). Therewas no significant difference between the number of
vessels in each category among the four groups tested.
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iron-containing A plaques (Benveniste et al., 1999) or cerebral
microbleeds (Klohs et al., 2011). These structures disappear in
the difference images, because they are not affected by the admin-
istration of the intravascular contrast agent (Fig. 2F). In addition,
in all animals few foci of reduced signal intensity have been de-
tected in the precontrast images. These are attributed to venous
structures for which the relatively high concentration of para-
magnetic deoxyhemoglobin leads to decreased blood T2* values
already in the absence of an exogenous contrast agent (Ogawa et
al., 1990; Reichenbach et al., 1997).
For illustration purposes, 3D stacks of difference images have
been constructed for computing of MIPs (Fig. 3). Clearly, these
MIPs provide significantly more detail about the vascular anat-
omy than those obtained from TOF angiograms, which essen-
tially reveal only large arterial structures. While CE-MIPs are
dominated by large vessels running at the brain surface, such as
the transverse and superior sagittal sinus, many transcortical ves-
sels become apparent (Fig. 3A,B). These can be highlighted by
visualizing a cortical subcube of the full 3D dataset (Fig. 3C–E).
CE-MRA reveals age-dependent decrease in transcortical
vessels
An algorithm was developed which assumes that blood vessels
form a continuous tree structure. Structures that exceeded a user-
defined intensity threshold in the 3D dataset derived from differ-
ence images were counted as vessels provided they fulfilled the
connectivity criterion, which states that the vessel can be ob-
served over multiple slices within the 3D dataset. The strength of
this criterion could be adjusted. The number of vessels was esti-
mated for different values of vessel connectivity i.e., 3, 6, and 9
pixels, corresponding to minimal length of a vessel segment of
183, 366, and 546m respectively. Using this algorithm, individ-
ual datasets have been analyzed in a semiautomated fashion. The
quantitative results on vessel counts are illustrated in Figure 4.
We did not observe any difference in vessel count in 4-month-old
wt and arcA mice (Fig. 4A). However, there was a significant
reduction in the number of transcortical vessels in 24-month-old
transgenic compared with wt animals in a volume of 11 mm3
(*p  0.05). Vessels were categorized according to their vessel
radius as estimated based on its signal intensity, which is gov-
erned by the fractional volume of the vascular compartment (Fig.
4B). There were no significant differences between the numbers
of vessels in each category among the four groups, though the
mean number of small (20–40 m) and medium sized (40–60
m) cortical vessels in the group of 24-month-old arcA mice
tended to be smaller than in the respective group of wt animals.
Abnormal fibrinolysis in small- andmedium-sized thioflavin
S-positive vessels
Immunohistochemical assessment of vascular density, A and
fibrinogen accumulation was performed on brain sections of
4- and 24-month-old wt and arcAmice. Confocal analysis iden-
tified endothelial cells (Fig. 5A–C). Additional vWF immunore-
activity was revealed in thrombus-like structures in microvessels
of 24-month-old arcAmice only (Fig. 5C, white arrow). Quan-
titative analysis of vWF immunoreactivity demonstrated no dif-
ferences between the four groups investigated.
Thioflavin S-positive A accumulation was apparent in cere-
bral vessels in sections of 24-month-old arcAmice (Fig. 5C), but
was observed neither in sections of age-matched wt controls (Fig.
5B) nor in 4-month-old transgenic (Fig. 6A) and wt mice (data
not shown). Investigation of different anatomical regions re-
vealed a high abundance of thioflavin S-positive vessels in cortical
areas of 24-month-old arcAmice, while vessels in the thalamus
showed almost no A deposition (results not shown). Autofluo-
rescence of pigment granules were observed in 24-month-old wt
Figure 5. Assessment of the endothelial marker vWF (red) with immunohistochemistry. Nuclear staining was done with DAPI (blue). Representative confocal images of 4-month-old wt (A),
24-month-old wt (B), and 24-month-old arcAmice (C). The white arrow points to vWF immunoreactivity in thrombus-like structure in amicrovessel of a 24-month-old arcAmouse. There was
no difference in vWF immunoreactivity between arcA and wt controls at 4 months of age and between arcA and wt controls at 24 months of age (D; mean SD; t test). Scale bar: 10m.
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and arcA mice (Fig. 6B,C, white arrows). Such intracellular
lipofuscin aggregates were not observed in 4-month-old wt and
transgenic mice and are known to be a sign of the aging of neu-
rons (Dowson and Harris, 1981).
Fibrinogen accumulation was observed in vessels of 24-
month-old arcA mice (Fig. 6C). The fibrinogen accumulation
was always colocalized by thioflavin S-positive signal (Fig. 6G).
thioflavin S/fibrinogen-immunoreactivity clearly differed be-
tween vessel categories. In small- and medium-sized arteries,
thioflavin S/fibrinogen-positive signal was highly abundant,
whereas in larger vessels it was scarcely visible (Fig. 6D–F). Some
of the small vessels were filled by the fibrinogen deposition, indi-
cating vessel stenosis (Fig. 6D). Quantitative assessment of im-
munoreactivity showed highest thioflavin S/fibrinogen-positive
signal in vessels with a diameter between 20 and 40m(Fig. 6H).
Discussion
Apart from the formation of parenchymal plaques, cerebral am-
yloidosis also involves deposition of A peptides at vessels, which
may lead to vascular remodeling aswell as compromised function
of the cerebrovasculature. In the arcA transgenic mouse model,
age-dependent aberrations in the structure and function of the
cerebrovasculature have been reported (Princz-Kranz et al.,
2010; Klohs et al., 2011; Merlini et al., 2011). We used MRA
techniques to noninvasively assess cerebral vasculature. While
TOF-MRA did not display any pathological changes, CE-MRA
revealed a reduction in the density of the microvasculature in the
arcAmouse during advanced disease state.
TOF-MRA and CE-MRA can be used to assess different lev-
els of the vascular tree. In TOF-MRA the signal depends on the
blood flow (Lin et al., 1997), confining the method to the visual-
ization of large cerebral arteries with high blood-flow rates.High-
resolution TOF-MRA has been applied to transgenic mouse
models of AD and CAA, reporting prominent flow voids in the
major arteries of aged APP overexpressing transgenic animals
(Beckmann et al., 2003; Krucker et al., 2004; Thal et al., 2009; El
Tannir El Tayara et al., 2010). In contrast, we did not detect flow
voids in arcAmice. This is not surprising, because immunohis-
tochemical analysis revealed that A and fibrinogen deposition
prevails in small- and medium-sized cerebral vessels, but effec-
tively spares larger cerebral vessels. There was a trend toward a
Figure 6. Assessment of A and fibrinogen deposition in wt and arcAmice. Depicted are representative confocal images of 4-month-old arcA (A), 24-month-old wt (B), and 24-month-old
arcAmouse brain sections (C–F ) after thioflavin S staining (green) and antifibrinogen immunohistochemistry (red). The white arrows point to autofluorescence caused by lipofuscin aggregates,
which are typical findings in neurons of aged animals. Fibrinogen accumulation was seen only in thioflavin S-positive vessels in 24-month-old arcAmice. Fibrinogen accumulation colocalized
stronglywith A deposition (G; mean SD; *p 0.05 Student’s t test). Deposition of A and fibrinogenwere confined to small- andmedium-sized arteries andwere only scarcely visible in large
vessels (D–F ). The histogram depicts the cumulative frequency of the thioflavin S/fibrinogen immunoreactivity according to different categories of vessel diameter (H ). Scale bars: A–C, 10m;
D–F, 30m.
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reduced distality count in TOF MRI of 24-month-old compared
with4-month-oldmice, indicating a reducedblood flow in theolder
animals. ElTannir ElTayara et al. (2010) observed a reduction in the
length ofmiddle cerebral arteries both in agedAPP/PS1 andwt con-
trol mice. This effect can be attributed to a decline in blood flow
velocity due to aging (Vriens et al., 1989; Portman et al., 1992).
An intriguing finding in earlier TOF-MRA studies (Beckmann
et al., 2003; Krucker et al., 2004; Thal et al., 2009; El Tannir El
Tayara et al., 2010) was the observation of flow voids in extracra-
nial vessels, such as the pterygopalatine artery, in APP overex-
pressing mice. As the transgene is expressed under the control of
the Thy-1 promoter, A deposition should be confined to intra-
cerebral vessels. In the current study we observed similar flow
voids, however, both in arcA and wt mice of both age groups.
This finding is consistent with earlier reports in APP/PS1 and
age-matched wt mice (El Tannir El Tayara et al., 2010) and indi-
cates that the flow voids observed are neither linked to the A
pathology nor the genetic trait. Instead, their occurrence might
be attributed to susceptibility effects caused by the proximity of
the tympanic bulba to the petrygopalatine artery (El Tannir El
Tayara et al., 2010). Hence, in TOF-MRA the detectability of a
vessel may be compromised either by reduced blood flow rates
(Lin et al., 1997) or by local flow disturbances (Underwood and
Mohiaddin, 1993). The technique appears of limited value for
studying vascular remodeling inmousemodels of CAA that affect
medium-sized to small vessels characterized by low flow rates and
potential abnormalities in flow pattern.
Therefore, we exploited the use of CE-MRA, which is inde-
pendent of blood flow rates (Haacke et al., 1994; Lin et al., 1997;
Bolan et al., 2006). As contrast agent we intravenously injected
Endorem, which has a biphasic clearance kinetic (Majumdar et
al., 1990). Approximately 56% of the injected dose was estimated
to remain in the blood pool until the end of the postcontrast acqui-
sition. Hence, contrast-agent filled blood vessels (both arteries and
veins) could be clearly distinguished from stationary tissue.
By using CE-MRA, blood vessels smaller than the nominal
image resolution can be detected, because the area affected by
extravascular dephasing caused by the susceptibility difference
between vessel and stationary tissue exceeds the vessel dimen-
sions (Ogawa and Lee, 1990). Thus, significant changes in signal
can be observed even when the vascular compartment comprises
only a fraction of the voxel volume. We have used an algorithm
that counted the vessels in the differences images when they ful-
filled the criteria of Eq. 1. With this method, we found a signifi-
cantly reduced number of intracortical vessels (radii of 20–80
m) in a mouse model of cerebral amyloidosis, indicating that
noninvasive CE-MRA is sensitive in detecting vascular pathol-
ogy affecting the microvasculature. Yet, the resolution of the
method is not sufficient in resolving the status of capillaries with
a diameter of 7–10 m. Information about capillary density
may be inferred using stochastic approaches such as vessel size
imaging (Tropre`s et al., 2001).
Semiautomated analysis of CE-MRA datasets revealed a sig-
nificant reduction in the number of intracortical vessels in 24-
month-old arcA comparedwith aged-matchedwt controlmice,
whereas there was no difference between transgenic and wt mice
of 4 month of age. For verification of these findings, we investi-
gated the density of intracortical vessels in corresponding brain
section stained against the endothelialmarker vWF.We observed
no differences in expression levels of vWF among all groups,
indicating that intracortical vessels in the 24-month-old arcA
mice have not been lost. However, as the vessels of these mice
show some additional vWF immunoreactivity in nonendothelial
structures, we cannot rule out that this increase in vWF expres-
sion level has masked a potential decrease in immunoreactivity
due to vessel loss.
Vascular accumulation of A has been associated with the
deposition of fibrin which leads to the formation of clots that are
structurally abnormal and, hence, resistant to fibrinolysis (Paul et
al., 2007; Cortes-Canteli et al., 2010). Therefore, we used antifi-
brinogen immunohistochemistry to investigate whether the ves-
sels in the 24-month-old arcA mice were functionally altered.
Aggregation of fibrin(ogen) was evident in cortical vessels of 24-
month-old arcAmice, but not in 4-month-old arcAmice and
in none of the age-matched wt controls. Some of the smaller
blood vessels showed signs of stenosis due to the fibrin(ogen)
accumulation. Furthermore, in the aged arcAmice vWF immu-
noreactivity was observed in thrombus-like structures in cross-
sectioned blood vessels. As vWF displays also thrombogenic
functions (Ruggeri, 2007) this indicates that the vessels of aged
arA are prone to thrombus formation.
The aggregation of fibrin(ogen) was always coincident with
the vascular deposition of A, as indicated by the strong colocal-
ization of thioflavin S staining and fibrinogen immunoreactivity.
Vessels without A accumulation, e.g., in the thalamus, were also
devoid of fibrinogen. Furthermore, A/fibrinogen deposition
seems to preferentially occur in vessels of a radius of 10–40 m.
Despite the fact that the absolute vessel diameter estimates of
vessel diameter differ by factor 2–4 between the two methods
(MRI and histology) due to tissue shrinkage during the histolog-
ical preparation (Ratering et al., 2011), these vessels correspond
to the same vessel category, which were found to be significantly
reduced in number in the CE-MRA data. Together, these data
indicate that the reduction of the microvascular density in arcA
mice is due to a lack of perfusion of existing blood vessels as a
result of an altered thrombosis and fibrinolysis following vascular
A deposition.
In summary, high resolution CE-MRA revealed an age-
dependent reduction in the density of functional intracortical
vessels (radii of 20–80 m) in the arcA mouse. This class of
vessels is known to be preferentially affected by A accumulation
and seems to be prone to the formation of fibrin clots leading
ultimately to vessel stenosis. These results suggest that the mech-
anismof fibrin accumulationmight present therapeutic targets in
slowing the progression of A pathology. Due to its noninvasive
nature, CE-MRA provides a powerful tool to assess the dynam-
ics of cerebrovascular remodeling in the course of the disease
process and to evaluate therapeutic interventions inmousemod-
els of AD and CAA.
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